NEWARK, Calif., Sept. 12, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company’s programs and operations at the 6th Neurodegenerative Conditions Research and Development conference. Mr. McGlynn is scheduled to speak at 11:35 a.m. Pacific Time on Friday, September 14. The Neurodegenerative Conditions Research and Development session is part of the 2nd CNS Diseases World Summit which will be held September 13-14 at the Hilton San Francisco Financial District hotel in downtown San Francisco.
